In one of the most bizarre accidents of 2026, Eli Tomac and Justin Cooper crashed on Lap 4 of the second heat for Round 10 of ...
Bridging therapy was administered to 90% of apheresed patients, with chemotherapy ± radiotherapy used in 53% and targeted ...
Researchers at UC San Francisco have now developed a way to reprogram these cancer-fighting cells directly inside the body. This new method could remove the need for external manufacturing, ...
1. The introduction of HotSwap (TM) by CytoSorbents -- The New CytoSorb exchange system 2. The renewal of its long-standing partnership with Aferetica Srl in Italy, and 3. New clinical data ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
Universal month-3 NGF MRD negativity (10⁻⁵) followed short-course VRd or daratumumab-based induction and single-infusion ...
4d
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
Issued on behalf of Avaí Bio, Inc.Companies mentioned in this article: Avaí Bio (OTCQB: AVAI), FibroBiologics (NASDAQ: FBLG), Fate Therapeutics ...
The Citizens Life Sciences Conference 2026 March 11, 2026 1:40 PM EDTCompany ParticipantsSteven Harr - President, CEO ...
A new wave of immuno-therapies is reshaping the fight against cancer, turning the body’s own immune system into a powerful ...
Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and ...
UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective at fighting endometrial cancer than current immunotherapies in experimental models. While personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results